US 12233092
MSC-NTF specific exosomes and use thereof
granted A61KA61K35/28A61K38/00
Quick answer
US patent 12233092 (MSC-NTF specific exosomes and use thereof) held by BRAINSTORM CELL THERAPEUTICS LTD. expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BRAINSTORM CELL THERAPEUTICS LTD.
- Grant date
- Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K35/28, A61K38/00, A61K38/18, A61K38/1866